Acute hyperglycaemia is not associated with the development of atrial fibrillation in healthy pigs
Autor: | B. Zirngast, Ulrich Schotten, H. Maechler, Viktoria Herbst, Martin Manninger, David Zweiker, Martin Dobrovnik, Arne van Hunnik, U Rohrer, Andreas Zirlik, Daniel Scherr |
---|---|
Přispěvatelé: | Fysiologie, RS: Carim - Heart, RS: Carim - H08 Experimental atrial fibrillation |
Jazyk: | angličtina |
Rok vydání: | 2020 |
Předmět: |
0301 basic medicine
medicine.medical_specialty Refractory Period Electrophysiological Swine Population lcsh:Medicine 030204 cardiovascular system & hematology Arrhythmias medicine.disease_cause Article 03 medical and health sciences Electrocardiography 0302 clinical medicine Refractory Fibrosis Heart Conduction System Diabetes mellitus Internal medicine Heart rate Atrial Fibrillation Medicine Animals NETWORK education lcsh:Science POPULATION RISK HYPOTHERMIA education.field_of_study Multidisciplinary business.industry Diabetes lcsh:R Atrial fibrillation Hypothermia medicine.disease MODEL 030104 developmental biology CONDUCTION Hyperglycemia REGISTRY Acute Disease Cardiology lcsh:Q medicine.symptom business Pericardium Oxidative stress Biomarkers |
Zdroj: | Scientific Reports, Vol 10, Iss 1, Pp 1-7 (2020) Scientific Reports, 10(1):11881. Nature Publishing Group Scientific Reports |
ISSN: | 2045-2322 |
DOI: | 10.1038/s41598-020-68897-0 |
Popis: | Development and progression of atrial fibrillation (AF) is driven by comorbidities such as arterial hypertension and diabetes mellitus. In animal models of chronic hyperglycaemia, progression of AF has been proposed to be triggered by oxidative stress, apoptosis and fibrosis. Acute glycosylation of CaMKII has been associated with increased susceptibility to arrhythmias in acute hyperglycaemia. However, the proarrhythmogenic effect of acute hyperglycaemia has not been investigated. Nine healthy, anesthetized pigs (54 ± 6 kg) were instrumented with electrophysiologic catheters and a multielectrode array on the epicardium of the left atrial anterior wall. Left and right atrial effective refractory periods (AERP), inducibility of AF and left atrial epicardial conduction velocities (CV) were measured at baseline (BL), increasing steps of blood glucose (200–500 mg/dL in steps of 100 mg/dL by glucose infusion) and repeated after normalisation of blood glucose levels (recovery). Serum electrolytes were kept constant during measurements by means of sodium and potassium infusion. There were no significant differences in AERP, CV or AF inducibility between BL and recovery. Heart rate remained constant regardless of blood glucose levels (BL: 103 ± 18 bpm, 500 mg/dL: 103 ± 18 bpm, r = 0.02, p = 0.346). Mean left as well as right AERP increased with higher glucose levels. CV increased with glucose levels (1.25 (1.04, 1.67) m/s at BL vs. 1.53 (1.22, 2.15) m/s at 500 mg/dL, r = 0.85, p = 0.034). Rate of AF inducibility in the left atrium remained constant throughout the whole protocol (AF episodes > 10 s: mean inducibility of 80% at BL vs. 69% at 500 mg/dL, p = 0.32, episodes > 30 s: 0% at BL vs. 0% at 500 mg/dL, p = 0.17). Our data imply that acute hyperglycaemia is associated with lower arrhythmogenic substrate and does not promote AF inducibility. |
Databáze: | OpenAIRE |
Externí odkaz: | |
Nepřihlášeným uživatelům se plný text nezobrazuje | K zobrazení výsledku je třeba se přihlásit. |